Position in NVCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,108,463
+$10,067,825 QoQ
Shares Held
927,382
+29406.3% QoQ
Ownership
0.796%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $703,036,151 across 14 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
1,512,160 | $230,226,360 | |
| 2 | NEOG |
Neogen Corp
|
9,333,261 | $83,906,016 | |
| 3 | HAE |
Haemonetics Corp
|
1,101,371 | $82,602,825 | |
| 4 | PRCT |
PROCEPT BioRobotics Corp
|
3,265,704 | $73,739,596 | |
| 5 | ALMR |
Alamar Biosciences, Inc.
|
2,202,597 | $59,668,352 | |
| 6 | TXG |
10x Genomics, Inc.
|
1,266,954 | $48,575,016 | |
| 7 | QDEL |
QuidelOrtho Corp
|
1,743,563 | $30,547,223 | |
| 8 | IRMD |
Iradimed Corp
|
318,680 | $30,453,060 |
All Filings in NVCR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,108,463 | 927,382 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $40,638 | 3,143 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,214,903 | 945,426 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,781,379 | 718,055 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $50,375,141 | 1,690,441 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $43,859,858 | 2,806,133 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $29,333,292 | 1,712,393 | Shares | Sole | 2024-08-14 | |
| 2023-06-30 | $78,469,694 | 1,890,836 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $94,930,087 | 1,578,485 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,305,077 | 45,059 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||